Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration.
Manmeet K MamikEugene L AsahchopWing Fuk ChanYu ZhuWilliam G BrantonBrienne A McKenzieEric A CohenChristopher PowerPublished in: The Journal of neuroscience : the official journal of the Society for Neuroscience (2017)
HIV-associated neurocognitive disorders (HAND) represent a spectrum disorder of neurocognitive dysfunctions resulting from HIV-1 infection. Although the exact mechanisms causing HAND are unknown, productive HIV-1 infection in the brain with associated neuroinflammation is a potential pathogenic mechanism resulting in neuronal damage and death. We report that, in HIV-infected microglia cultures, insulin treatment led to reduced viral replication and inflammatory gene expression. In addition, intranasal insulin treatment of experimentally feline immunodeficiency virus-infected animals resulted in improved motor and memory performances. We show that insulin restored expression of the nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-γ), which is suppressed by HIV-1 replication. Our findings indicate a unique function for insulin in improving neurological outcomes in lentiviral infections, implicating insulin as a therapeutic intervention for HAND.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv aids
- type diabetes
- glycemic control
- human immunodeficiency virus
- gene expression
- hiv positive
- cerebral ischemia
- randomized controlled trial
- traumatic brain injury
- bipolar disorder
- sars cov
- oxidative stress
- poor prognosis
- inflammatory response
- cognitive impairment
- metabolic syndrome
- hiv testing
- adipose tissue
- binding protein
- combination therapy
- men who have sex with men
- subarachnoid hemorrhage
- mouse model
- south africa
- spectrum disorder
- working memory
- climate change
- molecular dynamics
- replacement therapy
- brain injury